ZA96403B - Racemisation - Google Patents
RacemisationInfo
- Publication number
- ZA96403B ZA96403B ZA96403A ZA96403A ZA96403B ZA 96403 B ZA96403 B ZA 96403B ZA 96403 A ZA96403 A ZA 96403A ZA 96403 A ZA96403 A ZA 96403A ZA 96403 B ZA96403 B ZA 96403B
- Authority
- ZA
- South Africa
- Prior art keywords
- compound
- alkylated
- piperidine
- racemisation
- racemised
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- LEBVLXFERQHONN-INIZCTEOSA-N levobupivacaine Chemical compound CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-INIZCTEOSA-N 0.000 abstract 1
- 229960004288 levobupivacaine Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- -1 piperidine-2-carboxanilide compound Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Rolling Contact Bearings (AREA)
- Optical Head (AREA)
- Beans For Foods Or Fodder (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9501071.6A GB9501071D0 (en) | 1995-01-18 | 1995-01-18 | Racemisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA96403B true ZA96403B (en) | 1997-01-20 |
Family
ID=10768271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA96403A ZA96403B (en) | 1995-01-18 | 1996-01-18 | Racemisation |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0804417B1 (de) |
| JP (1) | JP4015696B2 (de) |
| KR (1) | KR100404390B1 (de) |
| CN (1) | CN1172912C (de) |
| AT (1) | ATE242214T1 (de) |
| AU (1) | AU701221B2 (de) |
| BR (1) | BR9606821A (de) |
| CA (1) | CA2208522C (de) |
| DE (1) | DE69628540T2 (de) |
| DK (1) | DK0804417T3 (de) |
| ES (1) | ES2201166T3 (de) |
| FI (1) | FI117437B (de) |
| GB (1) | GB9501071D0 (de) |
| HU (1) | HU227426B1 (de) |
| MX (1) | MX9705428A (de) |
| NO (1) | NO308843B1 (de) |
| PL (1) | PL184091B1 (de) |
| PT (1) | PT804417E (de) |
| WO (1) | WO1996022281A1 (de) |
| ZA (1) | ZA96403B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0002246A (pt) * | 2000-04-06 | 2003-04-15 | Cristalia Prod Quimicos Farm | Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| ATE482695T1 (de) | 2002-12-13 | 2010-10-15 | Durect Corp | Orale darreichungsform mit flüssigen hochviskosen trägersystemen |
| BRPI0515372B8 (pt) | 2004-09-17 | 2021-05-25 | Durect Corp | composição líquida para fornecer anestesia local prolongada após administração a um indivíduo, e, uso de bupivacaína, acetato isobutirato de sacarose e álcool benzílico |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| PL2117521T3 (pl) | 2006-11-03 | 2012-11-30 | Durect Corp | Transdermalne systemy dostarczania zawierające bupiwakainę |
| WO2009075782A1 (en) | 2007-12-06 | 2009-06-18 | Durect Corporation | Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| CN102093284B (zh) * | 2010-12-29 | 2013-05-08 | 宜昌人福药业有限责任公司 | 富集哌啶-2-甲酰苯胺类旋光化合物的方法 |
| CA2905131A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US12274794B2 (en) | 2016-07-06 | 2025-04-15 | Orient Pharma Co., Ltd. | Oral dosage form with drug composition, barrier layer and drug layer |
| CN106187864B (zh) * | 2016-07-11 | 2018-11-23 | 江苏天和制药有限公司 | 一种由盐酸布比卡因制备高纯度布比卡因碱的方法 |
| CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
| CN116940358A (zh) | 2021-01-12 | 2023-10-24 | 度勒科特公司 | 持续释放药物递送系统和有关的方法 |
| WO2023158722A2 (en) * | 2022-02-16 | 2023-08-24 | Teva Pharmaceuticals International Gmbh | Processes for preparation of avacopan and intermediates thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2301498A1 (fr) * | 1975-02-20 | 1976-09-17 | Maggioni & C Spa | Methode pour la racemisation d'une lysine optiquement active |
-
1995
- 1995-01-18 GB GBGB9501071.6A patent/GB9501071D0/en active Pending
-
1996
- 1996-01-12 ES ES96900349T patent/ES2201166T3/es not_active Expired - Lifetime
- 1996-01-12 EP EP96900349A patent/EP0804417B1/de not_active Expired - Lifetime
- 1996-01-12 JP JP52210296A patent/JP4015696B2/ja not_active Expired - Lifetime
- 1996-01-12 DE DE69628540T patent/DE69628540T2/de not_active Expired - Lifetime
- 1996-01-12 BR BR9606821A patent/BR9606821A/pt unknown
- 1996-01-12 AT AT96900349T patent/ATE242214T1/de active
- 1996-01-12 CN CNB961915242A patent/CN1172912C/zh not_active Expired - Lifetime
- 1996-01-12 CA CA002208522A patent/CA2208522C/en not_active Expired - Lifetime
- 1996-01-12 MX MX9705428A patent/MX9705428A/es unknown
- 1996-01-12 HU HU9901418A patent/HU227426B1/hu unknown
- 1996-01-12 KR KR1019970704822A patent/KR100404390B1/ko not_active Expired - Lifetime
- 1996-01-12 PL PL96321378A patent/PL184091B1/pl unknown
- 1996-01-12 DK DK96900349T patent/DK0804417T3/da active
- 1996-01-12 PT PT96900349T patent/PT804417E/pt unknown
- 1996-01-12 WO PCT/GB1996/000067 patent/WO1996022281A1/en not_active Ceased
- 1996-01-12 AU AU43948/96A patent/AU701221B2/en not_active Expired
- 1996-01-18 ZA ZA96403A patent/ZA96403B/xx unknown
-
1997
- 1997-07-17 FI FI973040A patent/FI117437B/fi not_active IP Right Cessation
- 1997-07-17 NO NO973312A patent/NO308843B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4015696B2 (ja) | 2007-11-28 |
| EP0804417A1 (de) | 1997-11-05 |
| AU701221B2 (en) | 1999-01-21 |
| PL321378A1 (en) | 1997-12-08 |
| DE69628540T2 (de) | 2004-01-08 |
| MX9705428A (es) | 1997-11-29 |
| HUP9901418A2 (hu) | 1999-08-30 |
| KR100404390B1 (ko) | 2004-01-31 |
| PT804417E (pt) | 2003-09-30 |
| ES2201166T3 (es) | 2004-03-16 |
| ATE242214T1 (de) | 2003-06-15 |
| FI973040A0 (fi) | 1997-07-17 |
| HU227426B1 (en) | 2011-05-30 |
| EP0804417B1 (de) | 2003-06-04 |
| DK0804417T3 (da) | 2003-10-06 |
| CN1172912C (zh) | 2004-10-27 |
| NO973312D0 (no) | 1997-07-17 |
| CA2208522C (en) | 2007-03-13 |
| NO308843B1 (no) | 2000-11-06 |
| DE69628540D1 (de) | 2003-07-10 |
| BR9606821A (pt) | 1997-12-23 |
| WO1996022281A1 (en) | 1996-07-25 |
| AU4394896A (en) | 1996-08-07 |
| PL184091B1 (pl) | 2002-08-30 |
| KR19980701432A (ko) | 1998-05-15 |
| CA2208522A1 (en) | 1996-07-25 |
| HUP9901418A3 (en) | 2001-01-29 |
| GB9501071D0 (en) | 1995-03-08 |
| FI973040L (fi) | 1997-07-17 |
| FI117437B (fi) | 2006-10-13 |
| NO973312L (no) | 1997-07-17 |
| CN1168134A (zh) | 1997-12-17 |
| JPH11501905A (ja) | 1999-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9501071D0 (en) | Racemisation | |
| UA32566C2 (uk) | Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану | |
| EP0861262A4 (de) | Gruppen zum einfangen von nukleinsäuren | |
| DE69623460D1 (de) | Verfahren zur herstellung von 3-haloalkyl-1h-pyrazole | |
| AU3738597A (en) | Molecular model for vla-4 inhibitors | |
| ATE215612T1 (de) | Methode zur dissoziation von biotin komplexen | |
| ATE335511T1 (de) | Ein verfahren zur inhibierung der komplementaktivierung über einen alternativen weg | |
| ID17698A (id) | Proses untuk memproduksi asam l-glutamat dengan fermentasi | |
| DK0859766T3 (da) | Chirale methylphenyloxazolidinoner | |
| MX9702210A (es) | Procesos de racemisacion y transformacion asimetrica usados en la manufactura de levobupuvacaina y sus analogos. | |
| PT98205A (pt) | Processo para a preparacao de novos derivados beta-lactamicos | |
| ATE417100T1 (de) | Eine verbesserte immobilisierte penicillin g acylase | |
| MX9800412A (es) | Preparacion de 3-hidroxipirazoles n-substituidos. | |
| ATE197150T1 (de) | Verfahren zur herstellung von dihydroxypyrimidin- derivaten | |
| AU1278801A (en) | Method for generating information related to the molecular structure of a biomolecule | |
| ES2002393A6 (es) | Un procedimiento para la preparacion de derivados del acido n-alquil-6-metilergolin-8-carboxilico. | |
| ATE213782T1 (de) | Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate | |
| IT1250734B (it) | Procedimento per produrre l-lisina mediante fermentazione | |
| NZ332155A (en) | Improved process for the production of enantiomerically-pure azetidine-2-carboxylic acid | |
| DE59605545D1 (de) | Alkoholhaltige instant-getränkemischung, ihre herstellung und verwendung | |
| NO950807L (no) | Fremgangsmåte for fremstilling av karbonelektroder | |
| DE69803979D1 (de) | Verfahren zur herstellung von carboxamido-4-azasteroiden | |
| IL150638A0 (en) | Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8 [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one | |
| DE69802171D1 (de) | Verfahren zur herstellung von 10,11-dihydro-5h-dibenzo(a,d)cyclohept-5-enen und ihren derivaten | |
| ATE301625T1 (de) | Verfahren zur herstellung von 2,6- dimethylnaphthalin |